Evidence map›Paper›PMID 39705156›Full record

ArticleJournal of cellular and molecular medicine2024

Tubastrine, an antioxidant molecule from Tubastraea tagusensis sun coral, in the reversion of oxidative stress and neuron's death induced by Aβ42.

Amanda G Silva, João Vitor Cerávolo Rostirola, Filipe Duo Speri, Juliana Guanaes Pina, Marcelo V Kitahara, Giovanna B Longato, Juliana M Sciani

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Marine natural products.Natural product reports · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amanda G SilvaLaboratório de Produtos Naturais, Universidade São Francisco, Bragança Paulista, Brazil.
João Vitor Cerávolo RostirolaLaboratório de Produtos Naturais, Universidade São Francisco, Bragança Paulista, Brazil.
Filipe Duo SperiLaboratório de Produtos Naturais, Universidade São Francisco, Bragança Paulista, Brazil.
Juliana Guanaes PinaLaboratório de Produtos Naturais, Universidade São Francisco, Bragança Paulista, Brazil.
Marcelo V KitaharaCentro de Biologia Marinha, Universidade de São Paulo, São Sebastião, Brazil.
Giovanna B LongatoLaboratório de Produtos Naturais, Universidade São Francisco, Bragança Paulista, Brazil.
Juliana M ScianiLaboratório de Produtos Naturais, Universidade São Francisco, Bragança Paulista, Brazil.ORCID 0000-0001-7213-206X

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/19929-6
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder involving mitochondrial dysfunction and consequent production of reactive oxygen species (ROS), generated after amyloid peptide (Aβ42) accumulation. In this study, we isolated a new antioxidant molecule from the sun coral Tubastraea tagusensis and analysed it in cells exposed to oligomeric amyloid-beta peptide 1-42 (oAβ42). The coral was collected and immersed in methanol for the release of compounds, which were submitted to antioxidant DPPH and FRAP activity-guided fractionation using solid-phase extraction and HPLC. An active pure molecule was analysed by mass spectrometry and tested in SH-SY5Y differentiated neurons previously exposed to 5 μM oAβ42. The isolated active molecule was identified as tubastrine, which could significantly inhibit the cell death caused by the amyloid peptide. Moreover, oAβ42 increased the percentage of ROS in neurons-like from 40% to 65%, and the treatment with tubastrine reduced it to 50%. The antioxidant power of neurons-like after oAβ42 decreased significantly, while the compound reversed it, reaching similar values to the untreated cells. Therefore, tubastrine can reverse an important pathophysiological mechanism of AD, oxidative stress, by increasing neuronal antioxidant power and reducing ROS levels, able to prevent neuron-like cell death caused by oAβ42.

Indexed as

Amyloid beta-PeptidesAnthozoaAntioxidantsCell DeathNeuronsOxidative StressPeptide FragmentsReactive Oxygen SpeciesAlzheimer DiseaseAnimalsCell Line, TumorHumansAmyloid beta-Peptidesamyloid beta-protein (1-42)AntioxidantsPeptide FragmentsReactive Oxygen SpeciesAlzheimer's diseaseantioxidantcoral moleculesoxidative stresstreatmenttubastrine

Identifiers

PMID39705156
PMCPMC11661463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.